You are here:
etonogestrel (Nexplanon)
Advice
Following an abbreviated submission:
etonogestrel 68mg implant (Nexplanon) is accepted for use in NHSScotland.
Indication under review: contraception.
In patients for whom a long-acting etonogestrel implant is an appropriate choice of contraception.
This formulation of etonogestrel implant is X-ray opaque, allowing verification of presence and location of implant.
Drug Details
| Drug Name: | etonogestrel (Nexplanon) |
|---|---|
| SMC Drug ID: | 655/10 |
| Manufacturer: | Merck Sharp and Dohme Ltd |
| Indication: | Contraception |
| BNF Category: | |
| Sub Category: | 7.3 Contraceptives |
| Submission Type: | Abbreviated Submission |
| Status: | Accepted |
| Date Advice Published: | 13 December 2010 |